Search for: "GLAXOSMITHKLINE" Results 181 - 200 of 1,801
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Nov 2020, 9:45 am by Steve Brachmann
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]
27 Oct 2010, 12:14 pm by The LBN Team
Altogether, GlaxoSmithKline sold 20 drugs with questionable safety that were made at a huge plant in Puerto Rico that for years was rife with contamination. [read post]
26 Oct 2010, 3:28 pm by The LBN Team
Altogether, GlaxoSmithKline sold 20 drugs with questionable safety that were made at a huge plant in Puerto Rico that for years was rife with contamination. [read post]
24 Feb 2010, 10:24 pm
Over the weekend, US Senators Charles Grassley and Max Baucus released a report accusing pharmaceutical company GlaxoSmithKline of knowing for years about the heart attack risk even before a 2007 study in the New England Journal of Medicine reported this dangerous side effect. [read post]
21 Dec 2008, 3:01 pm
GlaxoSmithKline AEVE (GSK), Article 82 EC has been brought a step further, and that the Commission, NCAs and national courts are now be able to sanction new forms of abuses. [read post]
20 Apr 2012, 8:39 am
The GlaxoSmithKline Company claimed that if the workers acted like outside sale representatives then they were, and then therefore, they were exempt from overtime pay laws whether or not they actually closed any sales. [read post]
2 Jul 2012, 2:57 am by Ben Vernia
On July 2, the Department of Justice announced the largest-ever healthcare fraud settlement, with GlaxoSmithKline. [read post]
18 Jan 2008, 9:16 am
Today I have come into possession of a GlaxoSmithKline letter dated January 16, 2008, which was delivered on January 17, 2007, sent from GlaxoSmithKline CEO Jean-Pierre Garnier to Senators Leahy and Specter regarding the Senate Judiciary Report on the Patent Reform Bill (S. 1145). [read post]
19 Feb 2008, 12:31 pm
It just came to my attention that last week the Patent Docs put up an excellent synopsis of the GlaxoSmithKline v. [read post]
22 Feb 2010, 3:41 am by Bob Kraft
The diabetes drug Avandia, manufactured by GlaxoSmithKline, has been found to cause heart attacks and heart failure. [read post]
16 Oct 2009, 7:14 am
The family of Lyam Kilker sued GlaxoSmithKline in Philadelphia Common Pleas Court, blaming the... [read post]
30 Nov 2014, 9:38 am by Bloomberg
GlaxoSmithKline Plc’s Ebola vaccine produced responses from the immune system and didn’t raise safety concerns in a study with 20 healthy adults, completing an initial step toward making it widely available. [read post]
13 Jan 2011, 10:23 pm
When 60 Minutes aired an interview with the whistleblower in the GlaxoSmithKline class action lawsuit that alleged bad practices in the manufacturing procedures at the company's Puerto Rico plant, company officials had a lot to say in Glaxo [read post]
19 Apr 2012, 4:08 pm by Tom Huddleston Jr.
Human Genome Sciences has rejected British pharmaceutical giant GlaxoSmithKline's takeover bid. [read post]
15 Apr 2011, 10:03 am by Sue Reisinger
U.S. prosecutors re-indicted the former associate GC of GlaxoSmithKline on charges of obstruction and making false statements in a closely watched case that can set standards for reliance on outside counsel. [read post]
23 May 2007, 5:25 pm
Here's an excerpt:When GlaxoSmithKline settled a lawsuit three years ago with the State of New York over the antidepressant medication Paxil, the... [read post]
27 Feb 2019, 4:39 am
Slaughters and its clients such as GlaxoSmithKline, John Lewis and Vodafone will work with legal tech businesses on developing products. [read post]
15 Sep 2009, 4:57 pm
Jurors in Pennsylvania state court heard opening arguments Tuesday in the first trial of more than 600 cases alleging that GlaxoSmithKline hid information that its blockbuster antidepressant Paxil causes birth defects. [read post]
8 Sep 2010, 7:45 am by By JEFFERY CANE
GlaxoSmithKline, the British pharmaceutical giant, said that Simon Dingemans, head of the European M. [read post]